Glycogenosis Type IV (Andersen Disease)
What is Glycogenosis Type IV (Andersen Disease)?
Glycogenosis Type IV, also called Andersen Disease, is a rare inherited disorder that affects how the body stores and uses glycogen. Glycogen is a form of sugar that provides energy to cells. In this condition, the body produces abnormal glycogen that cannot be broken down properly.
The abnormal glycogen builds up in organs, especially the liver, muscles, and heart. This buildup causes tissue damage over time. The condition is caused by mutations in the GBE1 gene, which provides instructions for making an enzyme needed to form normal glycogen branches.
Most children with the classic form develop symptoms within the first year of life. The abnormal glycogen accumulation leads to progressive liver damage and cirrhosis. Without treatment, the condition can be life-threatening. Early detection through blood tests and genetic testing helps families plan for treatment options, including liver transplantation.
Symptoms
- Enlarged liver that can be felt during examination
- Failure to gain weight and grow at expected rates
- Muscle weakness and decreased muscle tone
- Yellowing of skin and eyes from liver damage
- Swollen abdomen from fluid buildup
- Enlarged spleen
- Developmental delays in motor skills
- Heart problems including cardiomyopathy in some cases
Some infants may seem healthy at birth but develop symptoms gradually during the first months of life. Others may have a milder, later-onset form with symptoms appearing in childhood or even adulthood.
Concerned about Glycogenosis Type IV (Andersen Disease)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Glycogenosis Type IV is caused by mutations in the GBE1 gene, which is inherited in an autosomal recessive pattern. This means a child must inherit one mutated gene from each parent to develop the condition. Parents who each carry one copy of the mutated gene typically show no symptoms themselves.
The GBE1 gene provides instructions for making glycogen branching enzyme. This enzyme is essential for creating properly structured glycogen with many branches. When the enzyme is deficient or absent, the body produces abnormal glycogen with long chains and few branches. This abnormal structure resembles plant starch more than normal glycogen. The immune system recognizes these deposits as foreign, triggering inflammation and progressive organ damage, particularly in the liver.
How it's diagnosed
Diagnosis begins with a physical exam and family history. Blood tests check liver enzymes like alanine aminotransferase, or ALT, which rises as liver cells are damaged by abnormal glycogen deposits. Progressive elevation of ALT levels can indicate worsening liver involvement and help doctors assess disease progression.
Additional testing includes liver biopsy to examine tissue under a microscope and identify abnormal glycogen deposits. Genetic testing confirms the diagnosis by identifying mutations in the GBE1 gene. Enzyme activity testing can measure glycogen branching enzyme levels in blood cells or tissue samples. Rite Aid offers blood testing that includes ALT monitoring, which can help track liver health in children diagnosed with this condition. Regular monitoring helps doctors determine the right timing for liver transplantation.
Treatment options
- Liver transplantation is the primary treatment for the classic hepatic form and can be lifesaving
- Regular monitoring of liver function through blood tests to track disease progression
- Nutritional support to maintain adequate calorie intake and growth
- Physical therapy to help maintain muscle strength and mobility
- Cardiac monitoring and treatment for heart involvement when present
- Management of complications like fluid buildup and infections
- Genetic counseling for families to understand inheritance patterns
- Coordination with specialists including hepatologists, geneticists, and transplant surgeons
Concerned about Glycogenosis Type IV (Andersen Disease)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Glycogenosis Type IV is a rare genetic disorder where the body produces abnormal glycogen that cannot be broken down properly. The abnormal glycogen accumulates in organs, especially the liver, causing progressive damage. It is caused by mutations in the GBE1 gene that affect glycogen branching enzyme function.
The condition follows an autosomal recessive inheritance pattern. A child must inherit one mutated GBE1 gene from each parent to develop the disease. Parents who carry one copy of the mutation are typically healthy but have a 25% chance with each pregnancy of having an affected child.
Most children show symptoms within the first year of life. Early signs include an enlarged liver, failure to gain weight, and muscle weakness. Some infants may appear healthy at birth but develop symptoms gradually over several months.
Blood tests can detect liver damage caused by the condition. Alanine aminotransferase or ALT levels rise as abnormal glycogen accumulates and damages liver cells. However, genetic testing is needed to confirm the diagnosis by identifying GBE1 gene mutations.
Elevated ALT indicates that liver cells are being damaged by abnormal glycogen deposits. Progressive increases in ALT levels suggest worsening liver involvement. Regular ALT monitoring helps doctors track disease progression and determine when liver transplantation may be needed.
Liver transplantation can be curative for the hepatic form of the disease. The transplanted liver produces normal glycogen branching enzyme, stopping the accumulation of abnormal glycogen. Early transplantation, before severe organ damage occurs, offers the best outcomes.
Children require frequent monitoring, typically every few months depending on disease severity. Blood tests check liver function through markers like ALT. Regular assessments help doctors track progression and plan treatment timing, particularly for liver transplantation.
Yes, there are several forms with varying severity and age of onset. The classic hepatic form appears in infancy with progressive liver disease. Other forms include a neuromuscular variant and a rare adult-onset form with milder symptoms affecting primarily muscles.
While most cases appear in infancy, a rare adult-onset form exists. Adults may develop muscle weakness, cardiomyopathy, or neurological symptoms. This form tends to progress more slowly than the classic childhood presentation.
Without treatment, the classic form is often fatal in early childhood due to liver failure. However, liver transplantation has significantly improved outcomes, with many children surviving into adulthood. Early diagnosis and timely transplantation are critical for the best prognosis.